Johann Sellner

ORCID: 0000-0001-8749-5533
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Long-Term Effects of COVID-19
  • Herpesvirus Infections and Treatments
  • Neurology and Historical Studies
  • Acute Ischemic Stroke Management
  • Polyomavirus and related diseases
  • Immunotherapy and Immune Responses
  • Infectious Encephalopathies and Encephalitis
  • SARS-CoV-2 and COVID-19 Research
  • Systemic Lupus Erythematosus Research
  • Cerebrovascular and Carotid Artery Diseases
  • Autoimmune Neurological Disorders and Treatments
  • Cerebral Venous Sinus Thrombosis
  • COVID-19 and Mental Health
  • Rheumatoid Arthritis Research and Therapies
  • History of Medicine Studies
  • Vector-borne infectious diseases
  • Mosquito-borne diseases and control
  • COVID-19 Clinical Research Studies
  • Viral Infections and Immunology Research
  • Cytomegalovirus and herpesvirus research
  • Mental Health and Psychiatry
  • History of Medical Practice
  • Traumatic Brain Injury and Neurovascular Disturbances

Landesklinikum Korneuburg
2019-2025

Paracelsus Medical University
2016-2025

Klinikum rechts der Isar
2016-2025

Technical University of Munich
2016-2025

Karl Landsteiner University of Health Sciences
2024-2025

Heidelberg University
2003-2024

German Cancer Research Center
2024

Christian Doppler Klinik
2013-2023

Medical University of Vienna
2014-2022

Göteborgs Stads
2020

Herpes zoster (HZ, shingles) is a frequent medical condition which may severely impact the quality of life affected patients. Different therapeutic approaches to treat acute HZ are available. The aim this European project was elaboration consensus-based guideline on management patients who present with HZ, considering different patient populations and localizations. This interdisciplinary aims at an improvement outcomes concerning disease duration, pain reduction in incidence postherpetic...

10.1111/jdv.13957 article EN Journal of the European Academy of Dermatology and Venereology 2016-08-31

Abstract Background The chemokines and cytokines CXCL13, CXCL12, CCL19, CCL21, BAFF APRIL are believed to play a role in the recruitment of B cells central nervous system (CNS) compartment during neuroinflammation. To determine which chemokines/cytokines show strongest association with humoral immune response cerebrospinal fluid (CSF), we measured their concentrations CSF correlated them cell subsets antibody levels. Methods Cytokine/chemokine were serum by ELISA patients non-inflammatory...

10.1186/1742-2094-9-93 article EN cc-by Journal of Neuroinflammation 2012-05-16

Although the main clinical features of COVID-19 infection are pulmonary, several associated neurological signs, symptoms and diseases emerging. The incidence characteristics complications unclear. For this reason, European Academy Neurology (EAN) core Task Force initiated a survey on observed in patients with infection.

10.1111/ene.14407 article EN European Journal of Neurology 2020-06-17

The development of intracranial hemorrhage (ICH) in acute ischemic stroke is associated with a higher neutrophil to lymphocyte ratio (NLR) peripheral blood. Here, we studied whether the predictive value NLR at admission also translates into occurrence hemorrhagic complications and poor functional outcome after endovascular treatment (EVT).We performed retrospective analysis consecutive patients anterior circulation who underwent EVT tertiary care center from 2012 2016. Follow-up scans were...

10.1186/s12974-018-1359-2 article EN cc-by Journal of Neuroinflammation 2018-11-15

Abstract Background An online 3-item survey was sent to the European Academy of Neurology (EAN) community and inquired about persistence SARS-CoV-2 vaccination skepticism underlying thoughts factors restricting vaccine use among patients with neurological conditions. Results We obtained 616 responses from 84 countries, predominantly Europe. In view treating neurologist, multiple sclerosis (MS), neuroimmunological disorders (ND), chronic infections continued have high levels toward...

10.1007/s10072-025-08017-w article EN cc-by Neurological Sciences 2025-02-04

Abstract Herpes zoster ( HZ , shingles) is a frequent medical condition which may severely impact the quality of life affected patients. Different therapeutic approaches to treat acute are available. The aim this European project was elaboration consensus‐based guideline on management patients who present with considering different patient populations and localizations. This interdisciplinary aims at an improvement outcomes concerning disease duration, pain reduction incidence postherpetic...

10.1111/jdv.13995 article EN Journal of the European Academy of Dermatology and Venereology 2016-11-02

CD20 depletion is a risk factor for unfavorable outcomes of COVID-19 in people with MS (pwMS). Evidence suggests that protective IgG response to mRNA-based vaccines B cell-depleted individuals limited. We studied the seroconversion after third mRNA SARS-CoV-2 vaccine pwMS limited or no standard immunization. Sixteen treated ocrelizumab rituximab received homologous vaccine, either Moderna mRNA-1273 Pfizer-BioNTech's BNT162b2 vaccine. quantified antibodies against spike receptor-binding...

10.3390/vaccines9121470 article EN cc-by Vaccines 2021-12-11

Abstract Background and purpose Despite the increasing number of reports on spectrum neurological manifestations COVID‐19 (neuro‐COVID), few studies have assessed short‐ long‐term outcome disease. Methods This is a cohort study enrolling adult patients with neuro‐COVID seen in consultation. Data were collected prospectively or retrospectively European Academy Neurology NEuro‐covid ReGistrY ((ENERGY). The at discharge was measured using modified Rankin Scale defined as ‘stable/improved’ if...

10.1111/ene.15293 article EN European Journal of Neurology 2022-02-23
Coming Soon ...